Cargando…

HLA Polymorphisms And TKI-Induced Liver Injury in Patients with Cancer: A Meta-analysis

Background: Tyrosine kinase inhibitors (TKIs) are widely used for patients with cancer, although liver injury has been observed in a small proportion of these patients. The aim of this study was to investigate the mechanisms underlying TKI-induced liver injury according to HLA polymorphisms. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Qian, Zhang, Zhuo, Wu, Yingchao, Zuo, Shuai, Liu, Qianxin, Liu, Tao, Wang, Xin, Cui, Yimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584402/ https://www.ncbi.nlm.nih.gov/pubmed/31258719 http://dx.doi.org/10.7150/jca.26727

Ejemplares similares

Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials
por: Hou, Jingyi, et al.
Publicado: (2023)

Co-expression and prognosis analyses of GLUT1–4 and RB1 in breast cancer
por: Zhang, Xiaodan, et al.
Publicado: (2021)

PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta‐analysis
por: Fan, Hongwei, et al.
Publicado: (2018)

Single-nucleotide polymorphisms of HLA and Polygonum multiflorum-induced liver injury in the Han Chinese population
por: Yang, Wan-Na, et al.
Publicado: (2020)

Validation of CPS+EG, Neo‐Bioscore, and modified Neo‐Bioscore staging systems after preoperative systemic therapy of breast cancer: Protocol of a retrospective multicenter cohort study in China
por: Xu, Ling, et al.
Publicado: (2018)

Case report: Secondary sclerosing cholangitis induced by lapatinib and vinorelbine in a metastasis breast cancer patient
por: Zhang, Zhuo, et al.
Publicado: (2021)

Identification of SPP1 as an Extracellular Matrix Signature for Metastatic Castration-Resistant Prostate Cancer
por: Pang, Xiaocong, et al.
Publicado: (2019)

Correlation of HLA-DP/DQ polymorphisms with transplant etiologies and prognosis in liver transplant recipients
por: Li, Yi, et al.
Publicado: (2017)

TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure
por: Lei, Jin, et al.
Publicado: (2022)

TKI safety
por: Hjorth-Hansen, Henrik
Publicado: (2019)

Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis
por: Xie, Qiufen, et al.
Publicado: (2022)

Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer
por: Zhang, Zhuo, et al.
Publicado: (2021)

Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis
por: Lin, Zhong-Hua, et al.
Publicado: (2010)

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury
por: Ohmori, Tohru, et al.
Publicado: (2021)

Meta-Analysis on the Relationship between HLA-DRBl Gene Polymorphism and Cervical Cancer in Chinese Population
por: Wei, Lin-zhen, et al.
Publicado: (2014)

Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR‐TKI treatment
por: Cao, Haixia, et al.
Publicado: (2016)

The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
por: Wang, Chunyu, et al.
Publicado: (2019)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

Association of HLA-DR3 and HLA-DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus
por: Xue, Ke, et al.
Publicado: (2018)

Clinical study of apatinib combined with EGFR‐TKI in the treatment of chronic progression after EGFR‐TKI treatment in non‐small cell lung cancer (ChiCTR1800019185)
por: Li, Xin, et al.
Publicado: (2020)

Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma
por: Lv, Jingzhu, et al.
Publicado: (2017)

Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma
por: Xu, Tao, et al.
Publicado: (2017)

The TKI Era in Chronic Leukemias
por: De Novellis, Danilo, et al.
Publicado: (2021)

HLA-G Polymorphism (rs16375) and Acute Rejection in Liver Transplant Recipients
por: Azarpira, Negar, et al.
Publicado: (2014)

Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China
por: He, Yayi, et al.
Publicado: (2017)

The roles of HLA-DQB1 gene polymorphisms in hepatitis B virus infection
por: Ou, Guojin, et al.
Publicado: (2018)

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
por: Cao, Peijun, et al.
Publicado: (2022)

Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C
Publicado: (1992)

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant
por: Zhao, Lihao, et al.
Publicado: (2019)

A retrospective study on the efficacy and safety of Endostar with chemotherapy in EGFR-TKI-resistant NSCLC
por: Han, Bing, et al.
Publicado: (2023)

EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI
por: Jung, Minkyu, et al.
Publicado: (2012)

HLA polymorphisms and risk of glioblastoma in Koreans
por: Choi, Sang-Soo, et al.
Publicado: (2021)

In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers
por: Alfirevic, Ana, et al.
Publicado: (2012)

Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
por: Xia, Guo-Hao, et al.
Publicado: (2014)

HLA-DRB1 polymorphisms and alopecia areata disease risk: A systematic review and meta-analysis
por: Ji, Conghua, et al.
Publicado: (2018)

Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis
por: Liu, Linlin, et al.
Publicado: (2021)

Association of HLA-DP/DQ and STAT4 Polymorphisms with HBV Infection Outcomes and a Mini Meta-Analysis
por: Liao, Yun, et al.
Publicado: (2014)

Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis
por: Yan, L, et al.
Publicado: (2012)

Association of HLA-DRB1 Gene Polymorphism with Risk of Asthma: A Meta-Analysis
por: Yao, Yingshui, et al.
Publicado: (2016)

Association of HLA-DRB1 polymorphism with Alzheimer's disease: a replication and meta-analysis
por: Lu, Rui-Chun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8febku80htiscckhopq4n2h3c6